BB Biotech AG (XSWX:BION) Net Change in Cash: CHF202 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:BION BB Biotech AG XSWX:BION
32 GF Score
Price CHF55.90
! 5 Warning Signs
View Full Analysis

What is BB Biotech AG Net Change in Cash?

BB Biotech AG XSWX:BION +0.72% 32 Net Change in Cash is CHF202 Mil as of Jun. 2026. GuruFocus rates XSWX:BION with a GF Score™ of 32/100. The stock has 5 warning signs investors should review.

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

BB Biotech AG's Net Change in Cash for the three months ended in Jun. 2026 was CHF-151 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2026 was CHF202 Mil.

BB Biotech AG Net Change in Cash Historical Data

* Premium members only.

The historical data trend for BB Biotech AG's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BB Biotech AG Net Change in Cash Chart

BB Biotech AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.98 -0.89 -1.45 -0.04 97.76

BB Biotech AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -68.02 79.78 16.28 256.76 -151.21
XSWX:BION
32GF Score
BB Biotech AG XSWX:BION
Net Change in Cash is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BB Biotech AG Net Change in Cash Calculation

BB Biotech AG's Net Change in Cash for the fiscal year that ended in Dec. 2025 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=309.145+0+-203.195+-8.191
=98

BB Biotech AG's Net Change in Cash for the quarter that ended in Jun. 2026

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-150.875+0+0+-0.336
=-151

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF202 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Change in Cash →
What does a Net Change in Cash of CHF202 Mil mean?
BB Biotech AG (XSWX:BION) has a Net Change in Cash of CHF202 Mil as of Jun. 2026. The net change in cash is the total change in cash and equivalents between the current period and the past period. View historical data for BB Biotech AG and its competitors.
Is BB Biotech AG's Net Change in Cash too high?
BB Biotech AG's current Net Change in Cash is CHF202 Mil. Overall, BB Biotech AG has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's Net Change in Cash compare to VRTX and REGN?
BB Biotech AG's Net Change in Cash of CHF202 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Change in Cash for a Biotechnology company?
A good Net Change in Cash depends on the Biotechnology industry context. However, Net Change in Cash should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Change in Cash mean?
A high Net Change in Cash can signal that a stock is expensive relative to its fundamentals. The net change in cash is the total change in cash and equivalents between the current period and the past period. View historical data for BB Biotech AG and its competitors. BB Biotech AG's current Net Change in Cash is CHF202 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (XSWX:BION) has a current Net Change in Cash of CHF202 Mil. The current Net Change in Cash is CHF202 Mil. BB Biotech AG's overall GF Score™ is 32/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Change in Cash calculated?
Net Change in Cash is calculated from a company's financial statements. For BB Biotech AG (XSWX:BION), the current Net Change in Cash is CHF202 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BB Biotech AG Business Description

Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
32GF Score

Get the complete analysis for XSWX:BION

Net Change in Cash is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF55.90
Price